BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND BTG1, P62324, 694, ENSG00000133639 AND Diagnosis
9 results:

  • 1. Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
    Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Ståhl O; Wettergren L; Lampic C
    Acta Oncol; 2023 Dec; 62(12):1599-1606. PubMed ID: 37909865
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Performance of Neck Imaging Reporting and Data System (NI-RADS) for diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    Baba A; Kurokawa R; Kurokawa M; Yanagisawa T; Srinivasan A
    AJNR Am J Neuroradiol; 2023 Oct; 44(10):1184-1190. PubMed ID: 37709352
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis.
    Xing Z; Qiu Y; Yang Q; Yu Y; Liu J; Fei Y; Su A; Zhu J
    Eur J Radiol; 2020 Aug; 129():109103. PubMed ID: 32574937
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
    Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The prophylactic operational model integrated with occupational healthcare - Prophylactic of some types of cancers among women].
    Wiszniewska M; Magnuska J; Lipińska-Ojrzanowska A; Pepłońska B; Hanke W; Kalinka J; Skręt-Magierło J; Zadrożny M; Walusiak-Skorupa J
    Med Pr; 2018 Aug; 69(4):439-455. PubMed ID: 30038434
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Direct costs of cervical cancer management in Morocco.
    Berraho M; Najdi A; Mathoulin-Pelissier S; Salamon R; Nejjari C
    Asian Pac J Cancer Prev; 2012; 13(7):3159-63. PubMed ID: 22994727
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of payer status on treatment of cervical cancer at a tertiary referral center.
    Levinson KL; Bristow RE; Donohue PK; Kanarek NF; Trimble CL
    Gynecol Oncol; 2011 Aug; 122(2):324-7. PubMed ID: 21620446
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
    Wilgenbusch H; Mueller G; Neal M; Renshaw AA
    Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up.
    Giorgi Rossi P; Baiocchi D; Ciatto S;
    Acta Cytol; 2010; 54(3):265-71. PubMed ID: 20518409
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.